Skip to content
Sign in
Health · North America

Maharashtra FDA resolves 72% of 13,857 complaints in three months; AI filters out over 11,000 invalid submissions

Maharashtra’s FDA resolved 9,955 of the 13,857 complaints submitted through its online portal in the three months after its launch. The administration issued notices linked to 4,068 complaints escalated over delays, while 2,869 complaints remained under investigation and 1,033 were awaiting investigation.

AI-assisted synthesis · Based on 2 outlets' reporting · Full text read from 1 of 2 outletsHow it's made

View timeline · 4 entries
2 outletsLatest reporting 3 min read
Coverage: Too few ratedL 0 · C 2 · R 0
Updat3 graphic: Technology
Updat3 graphic

What happened

Key facts

  • The Maharashtra FDA resolved 9,955 complaints, nearly 72% of the total, in the three months after the portal launched (per freepressjournal.in).
  • The FDA reported 2,869 complaints under investigation and 1,033 awaiting the start of an investigation (per freepressjournal.in).
  • The administration issued notices concerning 4,068 complaints escalated because of delays (per freepressjournal.in).
  • Tukaram Mundhe said the number of escalated complaints corresponded to a similar number of notices issued to the officials concerned (per freepressjournal.in).
  • The Hindu headline says AI filtered out more than 11,000 invalid submissions (per The Hindu).

The brief

Maharashtra’s Food and Drug Administration resolved 9,955 of the 13,857 complaints submitted through its online portal during its first three months, the Free Press Journal reported. The outlet described the resolved share as nearly 72%.

The Hindu’s headline also says the FDA resolved 72% of 13,857 complaints in three months and reports that artificial intelligence filtered out more than 11,000 invalid submissions. FDA Commissioner Tukaram Mundhe launched the portal on July 14. The Free Press Journal said the system enables citizens to report food-safety and drug-related violations.

The outlet did not provide further details about how the portal processes submissions or how the AI screening mentioned in The Hindu’s headline operates. The FDA’s figures, as reported by the Free Press Journal, show that 2,869 complaints were under investigation and another 1,033 were waiting for an investigation to begin.

Those categories account for the remaining complaints alongside the 9,955 marked resolved. The reported totals describe different stages of handling; they do not establish the outcome of complaints still being investigated or awaiting investigation.

The administration issued notices in connection with 4,068 complaints that had been escalated because of delays, the Free Press Journal reported. Mundhe said the number of escalated complaints corresponded to a similar number of notices sent to the officials concerned.

His statement links the notices to the delays and escalations, but the outlet did not report how many notices led to action or whether any officials faced further consequences. The FDA also observed increases in complaints during Ganeshotsav and the August 15 long weekend.

The Free Press Journal said the agency highlighted the need for closer monitoring of food businesses during periods of increased consumer activity. It did not specify the complaint totals during those periods or identify particular businesses.

The figures describe the portal’s early workload: complaints received, resolved, under investigation, awaiting investigation, and escalated over delays. The Hindu’s headline adds that AI filtered out more than 11,000 submissions as invalid, but does not state how that number relates to the 13,857 complaints or to the resolution figures.

The reported account does not explain the criteria for classifying a submission as invalid.

Why it matters

  • The FDA reported 13,857 complaints and 9,955 resolutions, while 2,869 remained under investigation and 1,033 were awaiting one; those figures show the volume handled across different stages.
  • Citizens use the portal to report food-safety and drug-related violations, and the FDA said complaint levels rose during Ganeshotsav and the August 15 long weekend.
  • The administration issued notices over delays linked to 4,068 escalated complaints, putting the officials concerned within the reported follow-up process.

What to watch next

  • Whether the FDA advances the 2,869 complaints it reported as under investigation.
  • Whether the FDA begins investigations into the 1,033 complaints reported as awaiting investigation.
  • Whether the officials concerned face further action after notices linked to 4,068 escalated complaints.
  • How the AI screening described in The Hindu’s headline relates to the portal’s complaint totals and resolution figures.

How it's being covered

Coverage analysisShow details
2 source articles · 2 unique outlets
Coverage mix: Too few rated· 2 Center
Where the outlets are based: Asia 100%
Coverage mix
Too few rated
Left
Center
Right
0 outlets
2 outlets
0 outlets
The marker shows coverage balance: each unique outlet counts once.
Geography
Where the outlets covering this story are based.
2 unique outletsDominant coverage: Asia
Limited coverage
  • Coverage is currently limited to 2 outlets.
How we measure coverage

How outlets' accounts compare

Updat3 does not yet have enough full reports to compare how outlets framed this story.

Timeline

Developments from this story's sources, dated background we compiled and fact-checked, and our earlier coverage. Each row says which.
  1. India passed the Drugs and Cosmetics Act, establishing the legal framework for regulating drugs and cosmetics.
    Background · compiled and fact-checked by Updat3
  2. India adopted the Drugs and Cosmetics Rules, setting out requirements including licensing and inspection.
    Background · compiled and fact-checked by Updat3
  3. The Union government’s Digital India programme, launched on July 1, 2015, made expansion of digital public services a national policy priority.
    Background · from our historical context
  4. In 2018, NITI Aayog published its National Strategy for Artificial Intelligence, setting out a policy framework for applying AI in areas including public administration.
    Background · from our historical context

How we got here

The Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, established the legal basis for licensing and inspecting drugs and cosmetics, while state authorities carry out much of the day-to-day enforcement. Maharashtra’s Food and Drug Administration operates under that system.

The Centralized Public Grievance Redress and Monitoring System (CPGRAMS), launched by India’s Department of Administrative Reforms and Public Grievances in 2007, provided a national online channel for submitting and tracking complaints to government departments.

Original sources

2 articles from 2 outlets · Asia · Show all

Every story links to the reporting it was built from. How we choose sources

Spotted a factual error, a broken link or a misleading summary? Tell us.